Artiva Biotherapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -666 | -662 | ||
EBITDA | -21,466 | -20,866 | -22,169 | -21,543 |
EBIT | -22,132 | -21,528 | -22,810 | -22,171 |
Net Income | -20,772 | -21,528 | -21,254 | -20,311 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -15,147 | -19,801 | -24,038 | -20,352 |
Cash | 26,701 | 25,508 | 28,468 | 30,401 |
Basic Shares | 24,444 | 24,481 | 24,378 | 24,341 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $251 | $33,492 | $4,931 |
Gross Profit | -2,597 | 251 | 33,492 | 4,931 |
EBITDA | -88,013 | -64,851 | -28,405 | -58,671 |
EBIT | -90,610 | -67,282 | -30,671 | -59,829 |
Net Income | -83,865 | -58,493 | -27,696 | -58,388 |
Net Change In Cash | 0 | 251 | 33,492 | 4,931 |
Free Cash Flow | -79,338 | -55,674 | -50,688 | -57,128 |
Cash | 26,701 | 40,235 | 53,504 | 102,531 |
Basic Shares | 24,444 | 24,363 | 23,281 | 17,583 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$0.84 |
2025-09-30 | -$0.88 |
2025-06-30 | -$0.87 |
2025-03-31 | -$0.83 |
